{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:39:13Z","timestamp":1790177953521,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/pai.0b013e3181e78ff8","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T23:55:35Z","timestamp":1290642935000},"page":"494-498","source":"Crossref","is-referenced-by-count":23,"title":["The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features"],"prefix":"10.1097","volume":"18","author":[{"given":"Shree G.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Gokden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan C.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni Michelle","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neriman","family":"Gokden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210126","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4065\/72.10.935","article-title":"Renal cell carcinoma: diagnosis based on metastatic manifestations.","volume":"72","author":"Wahner-Roedler","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R2-2-20210126","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14737140.9.3.373","article-title":"Recent advances in the systemic treatment of metastatic papillary renal cancer.","volume":"9","author":"Chowdhury","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"R3-2-20210126","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/cncr.22340","article-title":"Treatment outcome for metastatic papillary renal cell carcinoma patients.","volume":"107","author":"Ronnen","year":"2006","journal-title":"Cancer"},{"key":"R4-2-20210126","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.pai.0000213144.70148.8e","article-title":"Expression of renal cell carcinoma antigen RCC in renal epithelial and nonrenal tumors: Diagnostic implications.","volume":"15","author":"Bakshi","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R5-2-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00129039-200306000-00004","article-title":"Diagnostic utility of renal cell carcinoma marker in cytopathology.","volume":"11","author":"Gokden","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R6-2-20210126","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/PAS.0b013e318176dba7","article-title":"The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.","volume":"32","author":"Gokden","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R7-2-20210126","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1242\/dev.119.3.711","article-title":"Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development.","volume":"119","author":"Rothenpieler","year":"1993","journal-title":"Development"},{"key":"R8-2-20210126","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0022-5347(01)65751-3","article-title":"Pax-2: a developmental gene constitutively expressed in the mouse epididymis and ductus deferens.","volume":"156","author":"Oefelein","year":"1996","journal-title":"J Urol"},{"key":"R9-2-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/hupa.2001.22753","article-title":"Pax-2 expression in adult renal tumors.","volume":"32","author":"Daniel","year":"2001","journal-title":"Hum Pathol"},{"key":"R10-2-20210126","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/modpathol.3800320","article-title":"Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.","volume":"18","author":"Mazal","year":"2005","journal-title":"Mod Pathol"},{"key":"R11-2-20210126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1309\/9KWEA4W9Y94D1AEE","article-title":"Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.","volume":"127","author":"Memeo","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R12-2-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/PAS.0b013e318181b828","article-title":"Diagnostic implications of transcription factor Pax-2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.","volume":"33","author":"Gupta","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R13-2-20210126","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1309\/AJCPM7DW0XFHDHNY","article-title":"PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.","volume":"131","author":"Ozcan","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R14-2-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAI.0b013e3181d712ef","article-title":"Pax-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study.","volume":"18","author":"Zhai","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R15-2-20210126","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/00000478-200112000-00003","article-title":"Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody renal cell carcinoma marker.","volume":"25","author":"McGregor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R16-2-20210126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000478-200002000-00006","article-title":"Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.","volume":"24","author":"Avery","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R17-2-20210126","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.","volume":"13","author":"Chu","year":"2000","journal-title":"Mod Pathol"},{"key":"R18-2-20210126","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1309\/8VAV-J2FU-8CU9-EK18","article-title":"Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms; frequent expression in renal cell carcinoma and endometrial stromal sarcoma.","volume":"113","author":"Chu","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R19-2-20210126","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1073\/pnas.80.9.2618","article-title":"Coexpression of keratin- and vimentin- type intermediate filaments in human metastatic carcinoma cells.","volume":"80","author":"Ramaekers","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-2-20210126","first-page":"262","article-title":"Expression of intermediate filament proteins in thyroid gland and thyroid tumors.","volume":"50","author":"Miettinen","year":"1984","journal-title":"Lab Invest"},{"key":"R21-2-20210126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/01913128509055483","article-title":"Coexpression of intermediate filaments in human epithelial neoplasms.","volume":"9","author":"McNutt","year":"1985","journal-title":"Ultrastruct Pathol"},{"key":"R22-2-20210126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00000478-198608000-00007","article-title":"Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.","volume":"10","author":"Dabbs","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R23-2-20210126","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary mullerian system origin.","volume":"20","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"R24-2-20210126","first-page":"4092","article-title":"Expression of pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.","volume":"55","author":"Gnarra","year":"1995","journal-title":"Cancer Res"},{"key":"R25-2-20210126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1442-2042.2001.00244.x","article-title":"Aberrant expression of pax-2 mRNA in renal cell carcinoma tissue and parenchyma of the affected kidney.","volume":"8","author":"Igarashi","year":"2001","journal-title":"Int J Urol"},{"key":"R26-2-20210126","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","article-title":"Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.","volume":"25","author":"Liebovich","year":"2007","journal-title":"J Clin Oncol"},{"key":"R27-2-20210126","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2008.10.014","article-title":"Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear cell renal cell carcinoma.","volume":"56","author":"Huang","year":"2009","journal-title":"Eur Urol"},{"key":"R28-2-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.semdp.2005.11.004","article-title":"An immunohistochemical approach to the differential diagnosis of renal tumors.","volume":"22","author":"Skinnider","year":"2005","journal-title":"Semin Diagn Pathol"}],"container-title":["Applied Immunohistochemistry & Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00129039-201012000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:37Z","timestamp":1786041577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129039-201012000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e3181e78ff8","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}